BackScience 37 Holdings Overview

Science 37 Holdings EBIT

Track Science 37 Holdings's EBIT ($-46M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow

Quarterly EBIT

-$3.44M
86.4% YoY

As of Sep 30, 2023

Annual EBIT (TTM)

-$45.61M

Trailing 12 months ending Sep 30, 2023

Average EBIT (Comparison Companies)

EBIT History

EBIT Comparison

Annual EBIT Growth Rate (%)

Annual EBIT Growth (Absolute)

Science 37 Holdings (SNCE) FAQ

The latest EBIT for SNCE is $-46M as of September 2023. That is above the sector sector average of $-63M. Investors often review this figure alongside Science 37 Holdings's historical trend and sector peers before judging valuation or financial health.

Against its sector companies, SNCE currently prints $-46M for EBIT, while the sector average sits near $-63M. That is roughly 27.1% above the sector mean. Large gaps often invite a closer look at Science 37 Holdings's growth, margins, and balance sheet.

A EBIT figure of $-46M for SNCE is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. The sector average is about $-63M. Explore the charts below for those layers of context.

After noting SNCE's EBIT ($-46M), review year-over-year change, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.